klow-con and xeloda Management of adverse events other practical considerations in patients receiving capecitabine (Xeloda®) Xeloda for Metastatic Breast Cancer

Severe Health Risks Acromegaly-like Effects: Similar to Growth Hormone (GH) abuse, IGF-1 LR3 abuse can lead to acromegaly, a long-term condition in which body tissues get larger over time

The many paths ascending to ferroptosis

, patients with higher post-CPB IL-6 or IL-8 have more postoperative atrial fibrillation and longer ICU stays

doi: 10.3389/fimmu.2023.1190379 Summary Keywords tremelimumab, durvalumab, ipilimumab, nivolumab, immune checkpoint inhibitor, FAERS, adverse event Citation Li Z, Xie Y, Wang T, Liu Y, Tian Y and Hua Y (2025) Evaluating the toxicity profile of combination immune checkpoint inhibitors: a disproportionality analysis of real-world adverse events from the FDA Adverse Event Reporting System for tremelimumab, durvalumab, ipilimumab, and nivolumab